Harbin Gloria Pharmaceuticals (002437) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Harbin Gloria Pharmaceuticals (002437) has a cash flow conversion efficiency ratio of 0.084x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.89 Million ≈ $26.76 Million USD) by net assets (CN¥2.18 Billion ≈ $318.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Harbin Gloria Pharmaceuticals net asset quality index to measure how much of total assets are equity-financed.
Harbin Gloria Pharmaceuticals - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Harbin Gloria Pharmaceuticals's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Harbin Gloria Pharmaceuticals (002437) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Harbin Gloria Pharmaceuticals Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Harbin Gloria Pharmaceuticals ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sedlmayr Grund und Immobilien AG
F:SPB
|
N/A |
|
AMG Advanced Metallurgical Group NV
AS:AMG
|
-0.018x |
|
Shantou Dongfeng Printing Co Ltd
SHG:601515
|
-0.004x |
|
Southern Cross Electrical Engineering Ltd
AU:SXE
|
-0.039x |
|
Grindrod
JSE:GND
|
0.030x |
|
Medartis Holding AG
SW:MED
|
0.088x |
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
|
0.092x |
|
Sichuan Crun Co Ltd
SHE:002272
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Harbin Gloria Pharmaceuticals (2007–2025)
The table below shows the annual cash flow conversion efficiency of Harbin Gloria Pharmaceuticals from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Harbin Gloria Pharmaceuticals worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.31 Billion ≈ $337.96 Million |
CN¥273.36 Million ≈ $40.00 Million |
0.118x | -43.18% |
| 2024-12-31 | CN¥1.97 Billion ≈ $288.69 Million |
CN¥410.94 Million ≈ $60.13 Million |
0.208x | +29.93% |
| 2023-12-31 | CN¥1.71 Billion ≈ $250.26 Million |
CN¥274.18 Million ≈ $40.12 Million |
0.160x | +4.39% |
| 2022-12-31 | CN¥1.70 Billion ≈ $249.28 Million |
CN¥261.62 Million ≈ $38.28 Million |
0.154x | +10.84% |
| 2021-12-31 | CN¥1.98 Billion ≈ $289.58 Million |
CN¥274.18 Million ≈ $40.12 Million |
0.139x | +1998.19% |
| 2020-12-31 | CN¥1.93 Billion ≈ $282.85 Million |
CN¥12.76 Million ≈ $1.87 Million |
0.007x | -98.28% |
| 2019-12-31 | CN¥1.59 Billion ≈ $232.45 Million |
CN¥610.37 Million ≈ $89.32 Million |
0.384x | +45.20% |
| 2018-12-31 | CN¥4.39 Billion ≈ $642.95 Million |
CN¥1.16 Billion ≈ $170.15 Million |
0.265x | +72.66% |
| 2017-12-31 | CN¥4.25 Billion ≈ $622.28 Million |
CN¥651.80 Million ≈ $95.38 Million |
0.153x | -40.39% |
| 2016-12-31 | CN¥4.05 Billion ≈ $592.15 Million |
CN¥1.04 Billion ≈ $152.26 Million |
0.257x | +27.19% |
| 2015-12-31 | CN¥3.47 Billion ≈ $508.18 Million |
CN¥702.05 Million ≈ $102.73 Million |
0.202x | -6.96% |
| 2014-12-31 | CN¥3.10 Billion ≈ $453.95 Million |
CN¥674.04 Million ≈ $98.63 Million |
0.217x | +18.87% |
| 2013-12-31 | CN¥2.48 Billion ≈ $362.66 Million |
CN¥453.02 Million ≈ $66.29 Million |
0.183x | +109.59% |
| 2012-12-31 | CN¥2.36 Billion ≈ $345.46 Million |
CN¥205.89 Million ≈ $30.13 Million |
0.087x | +49.01% |
| 2011-12-31 | CN¥2.20 Billion ≈ $321.54 Million |
CN¥128.61 Million ≈ $18.82 Million |
0.059x | +10.24% |
| 2010-12-31 | CN¥2.12 Billion ≈ $310.33 Million |
CN¥112.59 Million ≈ $16.48 Million |
0.053x | -91.06% |
| 2009-12-31 | CN¥287.53 Million ≈ $42.07 Million |
CN¥170.82 Million ≈ $25.00 Million |
0.594x | +99.41% |
| 2008-12-31 | CN¥194.04 Million ≈ $28.39 Million |
CN¥57.81 Million ≈ $8.46 Million |
0.298x | -21.12% |
| 2007-12-31 | CN¥138.36 Million ≈ $20.25 Million |
CN¥52.26 Million ≈ $7.65 Million |
0.378x | -- |
About Harbin Gloria Pharmaceuticals
HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd w… Read more